Rokos Capital Management (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Rokos Capital Management (UK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-333,934	Closed	-$19.5M	–	75
2023 Q3	$19.5M	Buy	+333,934	New	+$20.5M	0.14%	61
2022 Q3	–	Sell	-178,400	Closed	-$13.7M	–	80
2022 Q2	$13.7M	Sell	178,400 -326,227	-65%	-$24.8M	0.4%	47
2022 Q1	$37M	Hold	504,627	–	–	1.73%	16
2021 Q4	$31.7M	Buy	+504,627	New	+$29.6M	1.91%	9
2021 Q3	–	Sell	-1,145,738	Closed	-$76.6M	–	109
2021 Q2	$76.6M	Buy	+1,145,738	New	+$74.7M	1.53%	19

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rokos Capital Management (UK)'s BMY Position: Q4 2023 in Review

Rokos Capital Management (UK) sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 333,934 shares — an estimated $19.5M sold.

Rokos Capital Management (UK) first reported a position in BMY in Q2 2021 and held it in 5 quarters. The position peaked at $76.6M in Q2 2021. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Rokos Capital Management (UK) reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Rokos Capital Management (UK) sold 333,934 Bristol-Myers Squibb shares in Q4 2023, an estimated $19.5M.
Rokos Capital Management (UK) first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 5 quarters.
Rokos Capital Management (UK)'s Bristol-Myers Squibb position peaked at $76.6M in Q2 2021.
2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Rokos Capital Management (UK)'s 13F filing for Q4 2023, filed 14 Feb 2024.